Youngjun Kim
Clinical Pharmacology · Cypress, CANPI 1235661646
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$12,683,469in research payments, 2019–2025
Across 69 payments — averaging $183,818 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$7.3M
- E.r. Squibb & Sons, L.L.C.$3M
- Genentech, Inc.$1.4M
- Novo Nordisk AS$609K
- Arcutis Biotherapeutics, Inc.$188K
- Takeda Pharmaceuticals U.S.A., Inc.$75K
- plus $93K from 3 others
How this compares
Too few clinical pharmacology providers in Californiato place this figure against a meaningful peer group, so we don't.
Other clinical pharmacology in Cypress
- Jeffrey KittrelleSan Diego$261K
- Carl PeckSan Luis Obispo$30K
- Ferre' AkbarpourHuntington Beach$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.